"They're not shortcuts": How weight loss drugs became the business of shame
The use of GLP-1 drugs sparked the term "Ozempic shaming" to describe the negative perceptions faced by those who choose medical interventions for weight management. Some critics argue that using the drugs is akin to "taking a shortcut," overlooking the complex factors that contribute to obesity.
2don MSN
Hello, Health Rounds Readers! Today we feature a study that found yet another potential health benefit of GLP-1 drugs, this ...
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
8hon MSN
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss ...
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...
A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...
The National on MSN1d
Two years on, are GLP-1 drugs such as Ozempic and Mounjaro here to stay?In January 2023, the world was abuzz with stories of a revolutionary weight-loss drug – a simple, self-administered injection ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback